Compound A: Does it matter?

Canadian Journal of Anesthesia

Volumn 48, Issue 5, 2001, Pages 427-430

  Eger II, E I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBENT; ANESTHETIC AGENT; CARBON DIOXIDE; COMPOUND A; ETHER DERIVATIVE; FLUOMETHYL 2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL ETHER; SEVOFLURANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION; DRUG COST; EDITORIAL; FLOW RATE; HUMAN; KIDNEY INJURY; MAXIMUM ALLOWABLE CONCENTRATION; MEDICOLEGAL ASPECT; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034949719     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03028302     Document Type: Editorial

References (27)

1. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts
2. Toxicity of compound A in rats. Effect of a 3-hour administration
3. Toxicity of compound A in rats. Effect of increasing duration of administration
4. The safety of sevoflurane in humans: I
5. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats
6. Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-hour exposure, including kinetics of degradation products
7. 2 absorbents during low-flow anesthesia in surgical patients
8. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers
9. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia
10. Effects of low-flow sevoflurane anesthesia on renal function. Comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia
11. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity
12. Nephrotoxicity of sevoflurane vs. desflurane anesthesia in volunteers
13. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity
14. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers
15. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane
16. Dose-related biochemical markers of renal injury after sevoflurane vs. desflurane anesthesia in volunteers
17. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers
18. The effects of sevoflurane on serum creatinine and BUN concentrations: A retrospective, 22 center, comparative evaluation of renal function in adult surgical patients
19. The effects of inflow rate on breakdown products with soda lime in sevoflurane anesthesia
20. Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime
21. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme® and soda lime
22. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature
23. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption
24. Amsorb. A new carbon dioxide absorbent for use in anesthetic breathing systems
25. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide
26. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine
27. MAC of sevoflurane in humans and the New Zealand white rabbit